Russell Frank Company’s Biogen BIIB Stock Holding History

Russell Frank Company’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	$44.7M	Buy	171,852 +33,561	+24%	+$8.87M	0.08%	281
2015 Q4	$42.6M	Buy	138,291 +2,192	+2%	+$630K	0.07%	284
2015 Q3	$39.7M	Sell	136,099 -112,077	-45%	-$37M	0.07%	296
2015 Q2	$100M	Sell	248,176 -58,773	-19%	-$23.6M	0.16%	133
2015 Q1	$130M	Sell	306,949 -9,841	-3%	-$3.88M	0.24%	91
2014 Q4	$108M	Buy	316,790 +27,943	+10%	+$9.04M	0.19%	120
2014 Q3	$95.6M	Sell	288,847 -8,289	-3%	-$2.73M	0.17%	137
2014 Q2	$101M	Sell	297,136 -79,081	-21%	-$23.8M	0.18%	130
2014 Q1	$115M	Sell	376,217 -63,077	-14%	-$20M	0.2%	113
2013 Q4	$123M	Sell	439,294 -89,884	-17%	-$23.2M	0.23%	93
2013 Q3	$127M	Sell	529,178 -88,162	-14%	-$19.7M	0.22%	96
2013 Q2	$133M	Buy	+617,340	New	+$132M	0.24%	85

Other funds holding BIIB

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Russell Frank Company's BIIB Position: Q1 2016 in Review

Russell Frank Company increased its Biogen (BIIB) stake by 24% in Q1 2016, buying an estimated $8.87M and bringing the position to 171,852 shares worth $44.7M. The position accounts for 0.08% of the portfolio, ranked #281.

Russell Frank Company first reported a position in BIIB in Q2 2013 and has held it in 12 quarters since. The position peaked at $133M in Q2 2013. 948 funds tracked by Wall St. Rank hold BIIB as of Q1 2016.

Russell Frank Company held 171,852 shares of Biogen worth $44.7M as of Q1 2016.
Russell Frank Company bought 33,561 Biogen shares in Q1 2016, an estimated $8.87M.
Biogen made up 0.08% of Russell Frank Company's portfolio in Q1 2016, its #281 holding.
Russell Frank Company first reported a position in Biogen in Q2 2013 and has held it in 12 quarters since.
Russell Frank Company's Biogen position peaked at $133M in Q2 2013.
948 funds tracked by Wall St. Rank held Biogen as of Q1 2016.

Based on Russell Frank Company's 13F filing for Q1 2016, filed 29 Apr 2016.